Hager, Jeffrey H.
1005  results:
Search for persons X
?
3

Selective estrogen receptor degraders with novel structural..:

Govek, Steven P. ; Bonnefous, Celine ; Julien, Jackaline D....
Bioorganic & Medicinal Chemistry Letters.  29 (2019)  3 - p. 367-372 , 2019
 
?
5

Identification of an Orally Bioavailable Chromene-Based Sel..:

Nagasawa, Johnny ; Govek, Steven ; Kahraman, Mehmet...
Journal of Medicinal Chemistry.  61 (2018)  17 - p. 7917-7928 , 2018
 
?
6

Hormone-Targeted Therapy and Resistance:

Metcalfe, Ciara ; Friedman, Lori S. ; Hager, Jeffrey H.
Annual Review of Cancer Biology.  2 (2018)  1 - p. 291-312 , 2018
 
?
7

Optimization of an indazole series of selective estrogen re..:

Govek, Steven P. ; Nagasawa, Johnny Y. ; Douglas, Karensa L....
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  22 - p. 5163-5167 , 2015
 
?
8

Identification of GDC-0810 (ARN-810), an Orally Bioavailabl..:

Lai, Andiliy ; Kahraman, Mehmet ; Govek, Steven...
Journal of Medicinal Chemistry.  58 (2015)  12 - p. 4888-4904 , 2015
 
?
11

α-Mercaptoketone based histone deacetylase inhibitors:

Wash, Paul L. ; Hoffman, Timothy Z. ; Wiley, Brandon M....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  24 - p. 6482-6485 , 2008
 
?
12

Identification of KD5170: A novel mercaptoketone-based hist..:

Payne, Joseph E. ; Bonnefous, Céline ; Hassig, Christian A....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  23 - p. 6093-6096 , 2008
 
?
15

Tumor Cells Utilize Multiple Pathways to Down‐modulate Apop..:

HAGER, JEFFREY H. ; HANAHAN, DOUGLAS
Annals of the New York Academy of Sciences.  887 (1999)  1 - p. 150-163 , 1999
 
1-15